EP3302507
DIAGNOSTIC METHODS FOR T CELL THERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.5.2016EP published:
22.2.2023EP application number:
16800846.4
EPO information:
European Patent Register
Max expiry date:
26.5.2036
Title in English:
DIAGNOSTIC METHODS FOR T CELL THERAPYLanguage of the patent:
English
Timeline
Today
27.5.2016EP application
22.2.2023EP Publication
Owner
Name:
The United States of America, as represented by The Secretary, Department of Health and Human ServicesAddress:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660, US
Name:
Kite Pharma, Inc.Address:
2225 Colorado Ave., Santa Monica, CA 90404, US
Inventor
Name:
BOT, AdrianAddress:
California 90404, US
Name:
WIEZOREK, Jeffrey S.Address:
California 90404, US
Name:
GO, WilliamAddress:
California 90404, US
Name:
JAIN, RajulAddress:
California 90404, US
Name:
KOCHENDERFER, James N.Address:
Bethesda, Maryland 20892, US
Name:
ROSENBERG, Steven A.Address:
Bethesda, Maryland 20892, US
Priority
Number:
201562167738 PDate:
28.5.2015Country:
US
Number:
201562262111 PDate:
2.12.2015Country:
US
Classification
Categories:
A61K 35/17, A61K 38/20, C12N 5/0783, C12N 5/10, C12N 15/19, C12N 15/24, A61K 31/00, C07K 14/52, C07K 14/00, C12N 15/00, G01N 33/68, A61P 35/00, A61K 31/095, A61K 31/445, A61K 31/52, A61K 31/665, A61K 39/00, C07K 14/725